[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@SanofiUS Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::183033795.png) @SanofiUS Sanofi US

Sanofi US posts on X about $7846t the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::183033795/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::183033795/c:line/m:interactions.svg)

- X Week XXX +1,251%
- X Month XXXXX -XX%
- X Months XXXXX +162%
- X Year XXXXXX -XXX%

### Mentions: X [#](/creator/twitter::183033795/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::183033795/c:line/m:posts_active.svg)

- X Week X +300%
- X Month X +14%
- X Months XX +31%
- X Year XX +67%

### Followers: XXXXXX [#](/creator/twitter::183033795/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::183033795/c:line/m:followers.svg)

- X Week XXXXXX +0%
- X Month XXXXXX -XXXX%
- X Months XXXXXX -XXXX%
- X Year XXXXXX -XXXX%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::183033795/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::183033795/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::183033795/influence)
---

**Social category influence**
[stocks](/list/stocks) 

**Social topic influence**
[$7846t](/topic/$7846t)
### Top Social Posts [#](/creator/twitter::183033795/posts)
---
Top posts by engagements in the last XX hours

"#NEWS: The @US_FDA accepted the filing of our sBLA for recently diagnosed stage X #Type1Diabetes for expedited review through the FDA Commissioners National Priority Voucher (CNPV) pilot program. Learn more"  
[X Link](https://x.com/SanofiUS/status/1980238131082436899) [@SanofiUS](/creator/x/SanofiUS) 2025-10-20T11:42Z 80.3K followers, XXX engagements


"We have presented phase X data at #ESMO25 supporting the potential of our investigational therapy for gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Learn more CC: @OranoMed @RadioMedix"  
[X Link](https://x.com/SanofiUS/status/1980262983940067410) [@SanofiUS](/creator/x/SanofiUS) 2025-10-20T13:21Z 80.3K followers, XXX engagements


"Results from a phase X study evaluating an investigational treatment for alpha-1 antitrypsin deficiency (#AATD) achieved all primary and key secondary endpoints. Read our press release to learn more about our research on this #RareDisease"  
[X Link](https://x.com/SanofiUS/status/1980984694406857144) [@SanofiUS](/creator/x/SanofiUS) 2025-10-22T13:08Z 80.3K followers, XXX engagements